Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00218192 · ClinicalTrials.gov registry record · Phase 3

A Trial to Reduce Hepatitis C Among Injection Drug Users - 1

A Phase 3 study, sponsored by Butler Hospital.

Completed
Registry status
Phase 3
Development phase
277
Enrollment target

NCT00218192: Completed Phase 3 study, sponsored by Butler Hospital.

NCT00218192 is a Phase 3 study that has completed, run by Butler Hospital. The registered enrollment target is 277 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00218192, a Phase 3 study, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
Phase 3
Development phase
277 participants
Enrollment target

Study Summary

The purpose of this study is to examine the efficacy of a brief motivational intervention on the cumulative incidence of Hepatitis C.

Interventions

  • BEHAVIORAL Behavior Therapy

Trial Details

FieldValue
Enrollment Target 277 participants
Start Date 2000-09
Est. Completion 2006-11
Phase Phase 3
Butler Hospital

103 total trials

What the finished NCT00218192 record still lists

NCT00218192 is an interventional study that assigns participants to a tested intervention. The registered 277 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (64% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavior Therapy is the first listed.

NCT00218192 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00218192 about?

NCT00218192 is a clinical study titled "A Trial to Reduce Hepatitis C Among Injection Drug Users - 1". The purpose of this study is to examine the efficacy of a brief motivational intervention on the cumulative incidence of Hepatitis C.

What is the current status of trial NCT00218192?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 277 participants. The study started on 2000-09. Estimated completion is 2006-11.

What interventions are being tested in trial NCT00218192?

The interventions under investigation include: Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00218192?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00218192's enrollment target sits among peer trials

277 1202nd of 2000 higher than 799 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05818683 · 277 participants · Phase 1

    A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer

  • NCT06789913 · 277 participants · Phase 2

    A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation

  • NCT04586959 · 278 participants · NA

    Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

  • NCT05010148 · 278 participants · Phase 3

    A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00218192, the US trial registry maintained by the National Library of Medicine. NCT00218192 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.